About the Webinar
Discover how serum proteomics can support biomarker discovery and improve the stratification of Alzheimer's disease.
In this webinar, organized in collaboration with Olink, Part of Thermo Fisher, Dr. Betty Tijms presents recent advances in proteomics-based approaches and their clinical applications in neurodegenerative research.
Key Topics
In this webinar, you'll discover:
• How molecular profiling is changing our understanding of Alzheimer’s disease heterogeneity
• How proteomics and Olink Explore HT can help to identify subtypes linked to key biological pathways
• To what extent these subtypes may be detectable in blood
Betty Tijms
Head of Science at the Alzheimer Center Amsterdam,
Amsterdam UMC
